Previous Article | Next Article ![]()
Journal of Virology, August 2003, p. 8985-8999, Vol. 77, No. 16
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.16.8985-8999.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology,1 Center for Oral Health Research, School of Dental Medicine,2 Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 191043
Received 20 March 2003/ Accepted 13 May 2003
|
|
|---|
|
|
|---|
HVEM receptor activity is limited to wild-type HSV-1 and HSV-2, whereas nectin-1 acts as a receptor for many alphaherpesviruses (HSV-1, HSV-2, pseudorabies virus [PRV], and bovine herpesvirus 1) (13, 23, 43, 45, 47, 73). The related nectin-2 can be used only by HSV strains carrying specific mutations in the N-terminal part of gD and by HSV-2 (36, 72). Nectin-3 and nectin-4 are not receptors for herpesviruses, but the related human poliovirus receptor (PVR/CD155) can be used by animal herpesviruses such as PRV and bovine herpesvirus 1 (23, 55, 56, 59).
Nectins are widely expressed in tissues and cells (10, 16, 23, 25, 37, 40, 57), where they are located mainly at adherens junctions (AJ) (67). On the cell surface, nectins form homodimers involved in cell-cell adhesion by interacting in trans with other nectins (68). These calcium-independent trans-interactions can be homophilic or heterophilic within the nectin family (1, 67, 68).
Nectins share structural and sequence homology characterized by the presence of three Ig-like domains (one V-domain followed by two C-domains) in their extracellular portion. Isotypes of nectin-1 and nectin-2 generated by alternative splicing vary in their transmembrane region and cytoplasmic tails (10, 16, 23, 37). At least one variant of nectin-1, nectin-2, and nectin-3 (
-isotype) carries a C-terminal PDZ binding domain that is able to interact with afadin/AF6 (37, 38, 55, 59, 67). Afadin is a large protein produced as two isoforms, l-afadin and s-afadin (38, 68). The long form (l-afadin) contains an F-actin binding domain (38). Afadin also appears to be involved in mediating interactions between nectins and the cadherin-catenin system in AJ and between nectins and junctional adhesion molecules (JAM) in tight junctions (TJ) (19, 20, 66).
The V-domain of nectin-1 is critical in the trans-interaction of nectin-1 with itself or with nectin-3 (18, 33, 58, 65). HSV gD binds to the V-domain in a region involving the predicted ß-strands C, C', and C" (7, 8, 22, 34). In this region, mutations at positions between amino acids 64 and 94 abolish or decrease gD binding and receptor function (39, 42). It was shown that gD binding to the V-domain as well as HSV infection directly impaired the adhesive function of nectin-1 (33, 58, 77).
As a structural glycoprotein, gD is expressed relatively early after HSV infection (11). It is found on the surface of infected or transfected cells predominantly at cell contact areas (50, 65) and is targeted to basolateral membranes of epithelial cells (63).
Early in infection, nectin-1 seems to remain on the surface of cells in suspension; however, its epitope accessibility appears modified (33). In this study we qualitatively assessed the effects of HSV infection and gD expression on the cellular distribution of nectin-1 in cell monolayers. Under these conditions, natural AJs are formed and can be monitored directly. We used models consisting of murine melanoma cell lines transfected to constitutively express nectin-1 or nectin-1-green fluorescent protein (GFP) fusions as the only functional mediators of HSV entry (33, 44). First, cell lines carrying various nectin-1-GFP constructs were characterized for nectin-1 localization and ability to interact with afadin, mediate cell aggregation, and sustain HSV entry and spread. Surprisingly, we found that the nectin-1-afadin interaction was not required for nectin-1 accumulation at cell junctions or for efficient viral spread as proposed in earlier studies (58, 67). We further showed that the location of nectin-1 at AJ was altered during HSV infection and that newly synthesized gD was involved in this relocation. Observations by fluorescence microscopy of nectin-1 and gD in infected and transfected cells indicated that the two proteins colocalized at the interface between infected or transfected cells and naive cells, presumably by trans-interacting with each other. We propose a model in which gD plays a role in viral spread by replacing nectin-1 of infected cells at junctions with noninfected cells. By binding nectin-1 of the noninfected cell, gD would maintain the receptor at junctions in a position suitable for virus spread.
|
|
|---|
(ii) Cells. B78H1-C10 cells and B78H1-Control-16 cells, abbreviated here as C10 and B78 cells, respectively, were derived from B78H1 murine melanoma cells by transfection with pBG38 expressing human nectin-1 and the empty vector pcDNA3, respectively (33, 44). All B78H1-derived cell lines were cloned by limiting dilution in the presence of G418 (1 mg/ml) and subsequently maintained in Dulbecco's modified Eagle's medium with 5% fetal calf serum and G418 at 500 µg/ml.
(iii) Construction of nectin-1 with GFP fused at the C terminus. The nectin-1 open reading frame (ORF) from pBG38 (23) was directly flanked by HindIII and BamHI sites during PCR amplification using the forward primer FHC5HIND (GCCCAAGCTTATGGCTCGGATGGGGCTTGCGG) and the reverse primer RHC3BAM (GCGGGATCCCACGTACCACTCCTTCTTGG). The digested fragment was inserted into pCDNA3.1 (Invitrogen) that had been digested with HindIII and BamHI to yield plasmid pCK451. The enhanced GFP ORF from plasmid pEGFP (Clontech Laboratories Inc.) was flanked with BamHI and XbaI sites during PCR amplification with the forward primer 5'EGFP (CGCGGATCCATGGTGAGCAAGGGCGAGGAGCTGTT) and the reverse primer 3'GFP (CGGTCTAGACTACTTGTACAGCTCGTCCAT). The digested fragment was inserted into the corresponding sites of pCK451 to yield pCK454.
(iv) Construction of nectin-1 with GFP inserted into the cytoplasmic tail. First, a BamHI site was engineered into codons for Gly508 and Ser509 of plasmid pBG38 by using the Quickchange mutagenesis kit (Stratagene). The codons for Gly508 and Ser509 were changed from GGG TCT to GGA TCC without affecting the amino acid sequence. The mutated ORF was flanked by HindIII and BclI sites during PCR amplification using the forward primer FHC5HIND and the reverse primer RHC3BHL (GCGTGATCACACGTACCACTCCTTCTTGG). The digested fragment was introduced into pCDNA3.1 that had been digested with HindIII and BamHI to yield plasmid pCK453. The EGFP ORF was flanked by BamHI sites during PCR amplification using the forward primer 5'EGFP and the reverse primer REGFP3BAM (GCGGGATCCCTTGTACAGCTCGTCCATGCCGAG). The BamHI-digested fragment was inserted into the engineered BamHI site of pCK453, resulting in plasmid pCK455. In this construct, nectin-1 codons Gly508 and Ser509 are duplicated and flank the GFP ORF (Fig. 1).
![]() View larger version (18K): [in a new window] |
FIG. 1. Schematic representation of nectin-1 and derived fusion proteins. The 518-amino-acid human nectin-1 is represented by residues numbered from methionine 1. The open box indicates the nectin-1 signal peptide, and the transmembrane region (TMR) is hatched. The putative N-linked carbohydrates are represented by black lollipops. The Ig-like domains are labeled V, C, and C by analogy to variable or constant Ig domains. Sequences at GFP and CFP insertion sites are also shown. Capital letters represent the nectin-1 sequence, and lowercase letters represent the GFP and CFP start and end sequences. Asterisks indicate stop codons. The names of representative cell lines derived from B78H1 cells expressing the corresponding constructs are boxed. Nectin-1-GFP cell lines are CG23, CXG10, and NGC12. The NCC23 cell line expresses nectin-1-CFP, whereas C10 cells express wild-type nectin-1.
|
Plasmids pCK454, pCK455, pCK494 and pCK495 were transfected into B78H1 cells. Based on expression of the relevant fusion protein observed by fluorescence microscopy, several clones were selected for each construct. The resulting cell lines are B78H1-CG23 (nectin-1 with GFP at the C terminus), B78H1-CXG10 (GFP inserted 11 residues prior to the C terminus of nectin-1), B78H1-NGC12 (nectin-1 with GFP at the N terminus), and B78H1-NCC23 (nectin-1 with CFP at the N terminus) (Fig. 1).
Immunofluorescence. Cells were seeded on glass coverslips and cultured overnight to the desired density. They were fixed with 3% paraformaldehyde for 20 min at room temperature (RT), and then the remaining paraformaldehyde was quenched by incubation in 50 mM NH4Cl for 10 min at RT and the cells were permeabilized with 0.1% Triton X-100 for 5 min at RT (method adapted from that of Sodeik et al. [61]). Fixed cells were incubated in phosphate-buffered saline (PBS) with 10% normal goat serum for 30 min at RT and then labeled with the appropriate antibodies. The following antibodies were used: anti-AF6 (afadin) monoclonal antibody (MAb) (Becton-Dickinson, Transduction Laboratories), anti-gB MAb SS10 (G. H. Cohen and R. J. Eisenberg, unpublished data), and anti-gD polyclonal serum Ig (R7) (28) followed by an adequate Alexa-Fluor594-conjugated goat anti-Ig (Molecular Probes, Eugene, Oreg.). When required, MAb CK41 directly coupled to Oregon Green was subsequently added to detect nonfluorescent nectin-1 as described previously (32, 33). All incubations were performed in PBS plus 10% normal goat serum for 30 min at RT with 1 µg of purified IgG per ml. The coverslips were rinsed three times with PBS and once with H2O and mounted in ProLong Antifade (Molecular Probes). When required, nuclei were stained by the addition of DAPI (4',6-diamidino-2-phenylindole, 1 µg/ml) to the mounting solution. Preparations were examined with a Nikon Eclipse E600 microscope or with a Nikon TE-300 inverted microscope coupled to a Bio-Rad Radiance 2000-MP confocal imaging system. A two-line argon-krypton laser emitting at 488 and 568 nm was used to excite the fluorescence of Oregon Green and AlexaFluor 594.
Aggregation assay. The assay monitoring nectin-1-mediated cell aggregation was performed and analyzed as described previously (33). At the beginning (t = 0 min) and at the end (t = 90 min) of the aggregation time, aliquots of cells were fixed by adding 25% glutaraldehyde to a final concentration of 2% before the cells and aggregates were counted for quantitative analysis. Aggregation was reported as A90 = (N90/N0) x 100 where N90 and N0 represent the number of independent entities (clumps and individual cells) at incubation times t = 90 min and t = 0 min, respectively. Accordingly, the more aggregation, the lower the N90 value and therefore the lower the A90 percentage.
Alternatively, cells were fixed by the addition of 2 volumes of a 3% paraformaldehyde solution in PBS for direct observation of GFP by fluorescence microscopy (Nikon Eclipse E600 microscope).
Infections. (i) Entry assay.
Purified HSV-1 KOS tk12 (72) diluted in cell culture medium (100 µl) was added to confluent cell monolayers in 96-well plates at various multiplicities of infection (MOI). The cells were placed directly at 37°C and incubated for 6 h before being lysed with NP-40 (0.5% final concentration). Then, 50 µl of cell lysate was mixed with an equal volume of ß-galactosidase substrate (chlorophenol red-ß-D-galactopyranoside). The level of entry was monitored by reading the absorbance at 595 nm at intervals of 2 min for 50 min to record the enzymatic activity, expressed as the change in optical density per hour (
OD/h).
(ii) Blue-plaque assay. Cell monolayers were infected for 1 h at 4°C with HSV-1 KOS tk12 diluted in culture medium. The cells were incubated at 37°C for 2 h, and then the culture medium was replaced with an overlay of culture medium containing 0.5% methylcellulose. After 28 h at 37°C, the cells were washed three times with PBS and fixed with cold methanol-acetone (1:1). The enzymatic activity of the virus-encoded ß-galactosidase was detected by using 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal).
(iii) Immunofluorescence assay. Cells grown on glass coverslips were infected at high MOI (25 PFU/cell) for 1 h at 4°C with HSV-1 KOS tk12 diluted in culture medium. The virus inoculum was then removed, the cells were washed once with medium, and fresh warm medium was added. Incubation proceeded at 37°C for the indicated time. The cells were then fixed, permeabilized, and stained as described above.
Transfections. Subconfluent cell monolayers were transfected with the expression plasmid pPEP98 (gB) or pPEP99 (gD) (53) using GenePorter as recommended by the manufacturer (Gene Therapy System). After 24 h, the cells were trypsinized, seeded on glass coverslips, cultured overnight, and fixed and stained as described above. When mixed-cell experiments were performed, B78 cell populations were transfected with gD or gB expression plasmids and cultured for 24 h at 37°C before being mixed with receptor-expressing cells at a 1:1 ratio. Cocultures were grown on glass coverslips for an additional 24 h before being fixed and stained.
|
|
|---|
![]() View larger version (57K): [in a new window] |
FIG. 2. Expression of nectin-1 and nectin-1-GFP proteins in cell lines derived from B78H1 cells. Nectin-1 in B78H1 and C10 cells was detected using MAb CK41 coupled with Oregon Green (A and C), whereas nectin-1-GFP in CG23, CXG10, and NGC12 cells was observed directly by green fluorescence (E, G, and I). In these permeabilized cells, afadin was detected with anti-AF6 MAb followed by alexa594-coupled secondary antibody (B, D, F, H, and J). Representative pictures of various patterns are shown. These patterns are not cell-type specific and represent cell contact surfaces viewed from different angles (enlarged in panels E and F). Images A to F were collected on a regular fluorescence microscope (Nikon Eclipse E600), and images G to J were collected on a confocal microscope (Nikon TE-300 inverted microscope coupled to a Bio-Rad Radiance 2000-MP confocal imaging system).
|
Nectin-1-GFP constructs are functional adhesion molecules. Since nectin-1-GFP was found at cell junctions independently of afadin, we tested whether the various constructs could mediate cell adhesion in a functional aggregation assay by nectin-1-nectin-1 trans-interaction (1, 33, 67). In this assay, cells were trypsinized and resuspended as single cells, which were then allowed to aggregate over time at 37°C in the absence of calcium and magnesium ions (Fig. 3). As shown previously (33), the vector-transfected B78H1-control16 cells (B78) and A10 cells expressing HVEM/HveA showed only a moderate level of aggregation (Fig. 3A). In contrast, expression of nectin-1 induced significant aggregation of C10 cells (Fig. 3A) (33). Addition of GFP within (CXG10) or at the end (CG23) of the cytoplasmic tail of nectin-1 did not affect the ability of nectin-1 to trigger cell aggregation. Addition of CFP at the N terminus did not prevent nectin-1-mediated aggregation of NCC23 cells. However, NGC12 cells that express GFP instead of CFP at the N terminus of nectin-1 did not aggregate significantly above background levels (Fig. 3A). We think this is because NGC12 cells express less nectin-1 than NCC23 cells do (data not shown).
![]() View larger version (34K): [in a new window] |
FIG. 3. Cell aggregation mediated by nectin-1 and nectin-1-GFP. Various cell lines were trypsinized and resuspended in Hanks' balanced salt solution as a single-cell suspension. Trypsin treatment did not affect the detection of the nectin-1 ectodomain by fluorescence-activated cell sorter analysis (data not shown). Cells were then incubated at 37°C for 90 min or fixed immediately with glutaraldehyde (A) or paraformaldehyde (B and C). (A) Quantitative evaluation of nectin-1-mediated cell aggregation. Cells were observed under a microscope and scored as (N90/N0) x 100, where N90 and N0 are the total number of entities (clumps or single cells) observed at t = 90 and 0 min, respectively. Values are the mean and standard deviation of a triplicate representative experiment. A value of 100 indicates no aggregation; the lower the value, the greater the aggregation. White bars represent data at t = 0 min standardized to 100% for each cell line, and black bars represent data after a 90-min incubation. (B and C) CXG10 cells fixed after 0 min (B) or 90 min (C) of incubation at 37°C were observed for nectin-1-GFP localization as detected by green fluorescence emission. Insets show the same field as a phase-contrast image.
|
Nectin-1-GFP constructs are functional HSV entry mediators. The nectin-1-GFP-bearing cells were tested for their susceptibility to HSV entry and plaque formation. CG23, CXG10, and NGC12 cells were all susceptible to HSV entry compared to the control line, B78 (Fig. 4A). This indicates that all constructs served as receptors for HSV. This assay tests cell lines independently, and the results should not be used to compare the relative efficiency of constructs. Differences in expression levels of nectin-1 on the cell surface probably account for these variations (data not shown).
![]() View larger version (64K): [in a new window] |
FIG. 4. HSV infection mediated by nectin-1-GFP fusion proteins. (A) HSV entry. Cells were infected at various MOIs with HSV-1 KOS tk12 carrying the lacZ reporter gene. After a 6-h infection, the cells were lysed and ß-galactosidase activity ( OD595/h) was recorded as a measure of virus entry. (B) Plaque formation. Cell monolayers were infected with HSV-1 KOS tk12 for 28h. The plaques were visualized by X-Gal staining.
|
Lastly, Sakisaka et al. (58) showed a correlation between viral plaque size and the ability of nectin-1 to interact with afadin in transfected L cells. In their experiments, they infected L cells expressing a mutated nectin-1 that was unable to recruit afadin to junctions. There was inefficient spread, and the resulting plaques were reduced in size. We examined plaque size to assess the ability of the nectin-1-GFP constructs to promote virus spread. All cell lines carrying GFP at the N or C terminus or within the cytoplasmic tail of nectin-1 were equally able to support plaque formation without any noticeable change in plaque size from C10 cells (Fig. 4B). Thus, although afadin was not present at junctions in CXG10 and CG23 cells, in contrast to C10 cells (Fig. 2), virus spread appeared to be similar in all three cell lines.
Effects of HSV infection on nectin-1 localization. The various nectin-1 cell lines provide good models to study the consequences of HSV infection on nectin-1 distribution. Using C10 cells in suspension, we showed that nectin-1 was not immediately down-regulated from the cell surface during early times of HSV infection but that accessibility to certain epitopes was modified, possibly reflecting a structural change (33). Here we studied the redistribution of nectin-1 over time in infected cell monolayers (Fig. 5). When cells were incubated with virus for 1 h at 4°C (t = 0), nectin-1 was present at cell contact areas and had the same distribution as in mock-infected cells. As early as 1 to 3 h after a temperature shift to 37°C (1 to 3h postinfection [p.i.]), some nectin-1 was still detected at cell contact areas but much of it appeared to be in a distinct dotted pattern. At 4 h p.i. nectin-1 was found mostly in dots and very little was detected at cell contacts. However, the cells still contacted each other, and no obvious cytopathic effect was seen (Fig. 5, right panels). By 6 h p.i., cell morphology was more clearly affected. At this time, many cells appeared negative for nectin-1 staining while some still displayed the dotted pattern. These changes were observed in C10 cells, where nectin-1 was detected by MAb CK41 (Fig. 5). Similarly, nectin-1-GFP relocation was observed on infection of other nectin-1-expressing cells such as CXG10 and NGC12 (see Fig. 7A and 8C). Although we did not time specific events, we noted that in dense monolayers where cell junctions might be stronger, nectin-1 relocation appeared to occur slightly more slowly under our conditions of infection.
![]() View larger version (69K): [in a new window] |
FIG. 5. Detection of nectin-1 in infected cells. Subconfluent C10 cells were infected at high MOI with HSV-1 KOS tk12 as described in Materials and Methods. After a 1-h incubation at 4°C in the presence of virus, the cells were washed and incubated at 37°C for the indicated time before being fixed. Nectin-1 was detected with CK41-Oregon Green antibody (left panels). Phase-contrast images of the same fields are also shown (right panels). Arrowheads indicate the cell junctions where nectin-1 accumulated.
|
![]() View larger version (45K): [in a new window] |
FIG. 7. Nectin-1 detection after infection with gD-negative HSV-1. NGC12 cells were infected as above with HSV KOS tk12 (wild-type gD positive) (A) or with complemented HSV KOSgDß (gD negative) (B) for 6 h. As a control for infection, these cells were permeabilized and counterstained with an anti-gB MAb. The main pictures show nectin-1-GFP localization, and the insets show gB expression on the same field. The level of GFP fluorescence of cells infected with KOSgDß is much higher than that of the corresponding cells infected with KOS tk12. Therefore, image B was exposed for only half of the time used for image A. The insets have the same exposure time. Arrowheads indicate nectin-1 accumulated at junctions between two highly infected cells.
|
![]() View larger version (97K): [in a new window] |
FIG. 8. Colocalization of gD and nectin-1 between infected and noninfected cells. (A) Phase-contrast image from the observed field is shown to delineate cell morphology. i, infected cell; n, noninfected cell. (B) Nectin-1-GFP-expressing cells (CXG10) were infected at high MOI with HSV KOS tk12. Cells were fixed at 4 h p.i., permeabilized, and stained for gD expression. (C and D) Expression of nectin-1-GFP (C) and a merge picture where the yellow color indicates colocalization of nectin-1 and gD (D). Nuclei appear blue after DAPI staining (D). Arrows point to gD expressed in the Golgi system, and arrowheads indicate cell junctions.
|
![]() View larger version (69K): [in a new window] |
FIG. 6. Detection of nectin-1 and afadin during HSV infection. C10 cells were infected for 0 h (A to C) or 4 h (D to F) with HSV-1 KOS tk12 at high MOI. The cells were stained with MAb CK41 to detect nectin-1 (A and D) or with MAb anti-AF6 to detect afadin (B and E). Merged images are also shown (C and F). In panels A to C, arrowheads indicate examples of cell junctions where nectin-1 and afadin colocalize. In panels D to F, arrowheads points to dots where nectin-1 was found without colocalization with afadin.
|
Colocalization of gD with nectin-1 at cell contact areas. Since gD synthesis appeared to influence nectin-1 localization, it was of interest to investigate if, where, and when gD would interact with nectin-1. Redistribution of nectin-1 in B78H1-derived cell monolayers was observed before 3 h p.i. (Fig. 5). Synthesis of gD was shown to occur as early as 2 h after infection in KB epithelial cells as detected by radiolabeling (11). In this study, newly synthesized gD was not detectable under our immunofluorescence conditions at the early times of nectin-1 relocalization. By 4 h p.i., gD expression was clearly evident, notably by the intense staining at the perinuclear region (Golgi) and of cytoplasmic vesicles (Fig. 8B). Evidence of infection of CXG10 cells was also provided by the punctate pattern of nectin-1-GFP (Fig. 8C). Although some gD-containing vesicles were detected and some colocalization with nectin-1 could be observed, there was no defined overlay since many vesicles contained either gD or GFP only. Therefore, we could not definitively demonstrate colocalization between gD and nectin-1 in vesicles within the infected cell. Similarly, a high level of gD staining in the Golgi, where GFP could also be detected, does not imply specific association. However, gD did accumulate at areas where the infected cell contacted a neighboring noninfected cell (Fig. 8B). Nectin-1 was also very prominent at these locations (Fig. 8C), where it colocalized with gD (Fig. 8D). We did not observe any specific accumulation of gD at junctions between two infected cells (data not shown). Furthermore, gB did not show specific accumulation at junctions in any case (data not shown). Taken together, these data suggest that newly synthesized gD accumulated at cell junctions only when nectin-1 was present on the surface of the opposing cell.
So far we have only investigated cells infected at high MOI. We wanted to confirm these results in situ during an infection progressing in a cell monolayer. By observing HSV-1 plaques formed on CG23 cells expressing nectin-1-GFP, we were able to draw similar conclusions (Fig. 9). First, GFP fluorescence within plaques (counterstained for gD expression [Fig. 9B and C]) appeared less intense than in the surrounding monolayer (Fig. 9A). This correlated with the decreased detection of nectin-1 in infected cells described in Fig. 5. We then magnified the edge of a plaque where infected cells (stained for gD expression [fig. 9E]) contact noninfected CXG10 cells expressing nectin-1-GFP (Fig. 9D). On the periphery of the plaque, gD colocalized with nectin-1, presumably from the noninfected cells, as depicted by the yellow appearance of the typical "leopard skin" pattern of AJs (Fig. 9F).
![]() View larger version (86K): [in a new window] |
FIG. 9. Colocalization of gD and nectin-1 between infected and noninfected cells at the edge of plaques. CG23 cell monolayers were infected with HSV KOS tk12 for 24 h, fixed, and permeabilized. Nectin-1-GFP expression (A and D) and gD staining (B and E) are shown together with merged pictures (C and F). A low magnification of a confocal image of the periphery of a plaque is shown in panels A to C. A higher magnification of a fluorescent microscopy image from the edge of a plaque is shown in panels D to E. Arrowheads in panel A indicate nectin-1-GFP accumulation at cell junctions outside of the viral plaque. Arrowheads in panels D and E point to areas of colocalization of nectin-1 and gD at the periphery of the plaque.
|
Here we transiently transfected B78H1-CXG10 cells (nectin-1-GFP positive) with an expression plasmid for gD or gB (Fig. 10). Despite overexpression, gD accumulated preferentially at cell junctions, as evidenced by the leopard skin staining pattern of AJ surfaces (Fig. 10E). An identical pattern was visible for nectin-1-GFP (Fig. 10C), and the two overlapped on a merged picture (Fig. 10G). In contrast, when CXG10 cells were transfected with a gB expression plasmid, we observed a different pattern of expression of gB (Fig. 10F) and no colocalization with nectin-1 (Fig. 10H). These results indicate that gD specifically (at least compared to gB) accumulated at cell junctions without the requirement for other viral proteins. When B78H1 cells (nectin-1 negative) were transfected (Fig. 10I), gD was expressed on the cell surface; however, we did not observe specific accumulation of gD at cell contact areas as was seen in transfected CXG10, cells where gD displayed the typical pattern of cell contact surfaces. Therefore, nectin-1 governs the localization of gD, possibly by inducing its accumulation at cell junctions. Since high constitutive expression of gD occurred for a long time in transfected cells, we could not assess the effect of gD expression alone on nectin-1 within the transfected cell itself as we did after infection.
![]() View larger version (77K): [in a new window] |
FIG. 10. Colocalization of gD and nectin-1 in transfected cells expressing nectin-1. Cells expressing nectin-1-GFP (CXG10 cells) were transfected with an expression plasmid for gD (A, C, E, and G) or gB (B, D, F, and H). At 48 h after transfection, gD and gB were detected by immunostaining (E and F, respectively) whereas GFP was directly observed (C and D). Also shown are merged images (G and H). The yellow color indicates colocalization between gD and nectin-1-GFP (G), and nuclei appear blue after DAPI staining (G and H). As controls, nectin-1-negative B78 cells were transfected with the expression plasmid for gD (I and J). B78 cells are nectin-1 and GFP negative; therefore, the green channel and merged pictures have been omitted.
|
![]() View larger version (36K): [in a new window] |
FIG. 11. Colocalization of nectin-1 and gD expressed in adjacent cells. Nectin-1-deficient B78 cells were transfected with an expression vector for gD. At 24 h post-transfection, the cells were mixed with nectin-1-GFP-expressing cells (CXG10) and cocultivated for a further 24 h. (A) Fixed and permeabilized cells were stained with anti-gD antibody. (B) Nectin-1-GFP fluorescence was observed directly. The images in panels A and B were merged artificially to show colocalization (yellow) and cell nuclei (blue) (C).
|
|
|
|---|
Ability of nectin-1-GFP to function as cell adhesion molecules and HSV receptors. Nectin-1 is found predominantly at adherens junctions but also participates in tight junctions between epithelial cells (20, 67). At AJs, nectin-1 is part of a complex made of cytoplasmic proteins such as afadin or PAR-3 (20, 67). The nectin-1-afadin complex is connected to the well-characterized cadherin-catenin complex at AJs (66). These junctions are highly organized, and nectins are thought to play a key role in their establishment as well as their maintenance (68).
We found earlier that in B78H1 C10 cells, which express high levels of nectin-1, afadin accumulated at AJs, whereas in parental B78H1 cells, afadin had a cytoplasmic distribution (33). The nectin-1-GFP constructs confirmed that an intact afadin binding site at the C terminus of nectin-1 is required for the recruitment of afadin to AJs. In any case, nectin-1 or nectin-1-GFP constructs were found to accumulate at junctions only when a ligand (nectin-1 or nectin-1-GFP) was available for trans-interaction on the opposite cell. Taken together, our data suggest that nectin-1 is the driving force that recruits afadin to AJs in these cells. This is in partial agreement with published observations showing that nectin-1 or nectin-2 required both the trans-interaction with a ligand and the interaction with afadin in order to be clustered at cell-cell contact sites of L cells (46, 67). The importance of the role of afadin might be cell dependent and might involve other component of AJs. In addition, we found that even when afadin was not recruited to the junctions of CG23 or CXG10 cell monolayers, nectin-1-GFP was still able to promote efficient aggregation of these cells in suspension.
In a similar fashion, the addition of GFP to the PDZ binding domain of JAM-2 did not affect its propensity to accumulate at tight TJs (2). Furthermore, the accumulation of JAM-2 at TJs appears to require homo-trans-interaction of JAM-2 between adjacent cells (2).
The interaction between afadin and nectin-1 in transfected L cells was also reported to influence HSV spread in a plaque formation assay (58). Here we showed that nectin-1 that was fused to GFP at its N terminus or at the C terminus mediated efficient HSV entry. In addition, virus titers obtained on cells expressing the GFP constructs were similar to if not slightly higher than those on cells expressing regular full-length nectin-1 (C10 cells). No difference in plaque size was observed regardless of whether afadin colocalized with nectin-1 at cell junctions. Our results differ from the L-cell situation, where the expression of a nectin-1 mutant unable to interact with afadin resulted in a small-plaque phenotype for HSV infection (58). Again, this might be a cell type-dependent observation. The same site on nectin-1 was recently shown to also interact with PAR3 (69). Therefore, it is possible that other molecules might substitute for afadin function in B78H1-derived cells but not in L cells used by Sakisaka et al. (58). Our data suggest that the role of afadin might not be as essential as previously thought, although we cannot rule out an indirect role for this protein since afadin-deficient cells were not tested. It is possible that other molecules present in large cytoplasmic complexes at AJs, such as PAR3, are involved.
Effects of HSV infection on nectin-1 localization. Viruses use different strategies to down regulate the surface expression of their receptors (17, 21). We have shown that shortly after infection of cells in suspension, the accessibility of epitopes on nectin-1 was altered (33). These experiments suggested that nectin-1 was not down regulated from the cell surface since at least one epitope was still detected (33). Cell monolayers where junctions are present provide a much better model to observe the effects of infection on nectin-1 distribution. Clearly, the distribution of nectin-1 was drastically affected by HSV infection. In infected cells, nectin-1 no longer accumulated at cell junctions but, rather, was detected in a punctate pattern over the cell. Concomitantly, colocalization with afadin was lost. At later times, nectin-1 disappeared, as detected by MAb CK41 in C10 cells or by GFP fluorescence in cells expressing nectin-1-GFP. This relocation of nectin-1 depended on gD synthesis, since it did not occur after infection with a complemented gD-negative virus.
It is not clear yet by which mechanism gD affects nectin-1, but it is reasonable to postulate a direct interaction. gD might be involved in the active removal of nectin-1 from junctions, leading to the retargeting of nectin-1 to a different compartment. Indeed, since gD accumulated at cell junctions, this might be the result of active displacement of nectin-1. Alternatively, gD might interfere with targeting of nectin-1 to AJs, thus depleting nectin-1 from AJs by regular protein turnover. A high level of gD was detected in the Golgi apparatus during infection, where some level of colocalization with nectin-1 could be found, but a specific interaction was not clearly demonstrated. AJs can be remodeled, and it is not known how stable nectin-1 is once it is involved in cell adhesion; therefore both hypotheses are valid and remain to be tested. Once gD acted on nectin-1, the relocation of the receptor appeared quite specific; however the pathway that is involved needs to be clarified. In preliminary experiments, we were unable to associate the punctate pattern of nectin-1 in infected cells with early endosomes, late endosomes, or lysosomes as detected by the specific markers LAMP-1 and EEA-1 (data not shown). Regardless of which pathway and compartments are involved, it remains clear that HSV infection strongly affects nectin-1 expression via a mechanism involving gD.
Reciprocal influence of gD and nectin-1 on the accumulation of these proteins to cell junctions. Removal of nectin-1 from AJs appears to be a consequence of gD expression in infected cells. The newly expressed gD accumulated at cell contact areas with adjacent noninfected cells expressing nectin-1. Glycoprotein D targeting to vinculin-containing junction areas (AJs) was observed in HSV-infected Vero cells and was proposed to affect the integrity of these junctions (50). This early observation can now be explained by the presence of nectin-1 on Vero cells (32, 45). The accumulation of gD at cell contact areas driven by nectin-1 expressed in trans may result from an interaction between gD and nectin-1 which remains to be demonstrated directly. It suggests that each partner reciprocally recruits and maintains the other at cell contact areas. Indeed, nectin-1 does not accumulate at AJs unless it is involved in trans-interactions with a ligand (normally nectin-1 or nectin-3) (59). Here we showed that gD could fulfill the role of a ligand to maintain nectin-1 in a junction. We also hypothesized that the type of binding between nectin-1 and another nectin in trans is similar to the trans interaction with gD. It is known that gD binding interferes with nectin-1 homotypic trans interaction (33, 58); therefore, it is not unreasonable to think that gD binding mimics the binding of a natural ligand.
Biological significance of gD-nectin-1 interactions during HSV infection. The above observations lead us to propose a model consistent with our knowledge of gD-nectin-1 interactions during infection (Fig. 12). This simplified representation shows how the expression of gD in infected cells might lead to an alteration of nectin-1 cellular localization and to its replacement at junctions by gD. In turn, gD is probably acting as a ligand in trans for nectin-1 on the surface of a neighboring noninfected cell, although direct binding remains to be demonstrated under these circumstances. As a result, nectin-1 in the noninfected cell is maintained at junctions with the infected cells despite the down regulation of the cellular ligand.
![]() View larger version (53K): [in a new window] |
FIG. 12. Schematic representation of components of AJ, between two normal cells (left) and hypothetical contacts between a regular cell and an infected cell (right).
|
-catenin) (52, 66, 67, 69). The consequences of gD binding to nectin-1 in the context of virus spread as well as during HSV entry remain to be addressed from the signaling point of view. The accumulation of gD at cell contact areas at late times of infection might also play a more direct role in virus spread. It is possible that it might act as a tag to target outgoing capsids to regions on a nearby target cell. In this case, it might be a redundant mechanism since there is strong evidence that the gE-gI complex is important for sorting nascent virions to the junctions of epithelial cells (31; for a review, see reference 30). The gE-gI complex first accumulates at the trans-Golgi network, where nucleocapsids are enveloped, and then it is involved in sorting virus to the lateral cell surface of polarized cells. The trans-Golgi network accumulation of gE-gI requires an interaction between the cytoplasmic domain of gE and the cellular sorting machinery. At later times during infection, gE-gI is relocated to cell junctions and is postulated to drive the nascent virion AJ. Although accumulation of gE-gI at cell contact areas is mediated by the extracellular domain of gE, this region is not sufficient to promote cell-to-cell spread of HSV (76). A ligand for the gE-gI complex at AJ was postulated; however, it has not yet been identified (12, 15).
gD is required for HSV to spread from cell to cell (9, 27, 29, 35, 49), either because it acts as proposed above or, more basically, because its role as receptor binding protein is the same as during the entry of free particles (9). In PRV, gD is dispensable for virus spread (51, 54) even though PRV uses nectin-1 as a receptor for entry (23). However, PRV gD interacts with nectin-1 in a way similar but not identical to that used by HSV gD (13, 22, 45). This suggests that HSV gD might have two separate functions, but at present there are no gD mutants that are impaired in spread but not entry. This is reminiscent of the adenovirus fiber protein which binds directly to its receptor (CAR) during entry as part of virions and also during the virus release phase as a nonstructural protein (71).
In summary, the direct observations of nectin-1, afadin, and HSV glycoproteins, principally gD, during the course of infection suggest that reciprocal influences of gD and nectin-1 occur during different phases of infection. At early times p.i., nectin-1 is relocated from AJs within the infected cell and possibly targeted to degradation in a process that involves newly synthesized gD. At the periphery of the infection, specific accumulation of gD at cell junctions is driven by the presence of nectin-1 in the adjacent cell. This same naive cell is a putative target for infection, and it is our hypothesis that its nectin-1 is retained in junctions with the infected cell via an interaction with gD, thereby facilitating spread of the virus. This hypothesis on viral spread needs to be challenged and confirmed.
This investigation was supported by Public Health Service grants NS-30606 and NS-36731 from the National Institute of Neurological Disorders and Stroke (to R.J.E. and G.H.C.) and AI-18289 from the National Institute of Allergy and Infectious Diseases (to R.J.E. and G.H.C.).
|
|
|---|
(PRR2
or HveB) and nectin2
are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 74:1267-1274.
are ligands for herpesvirus entry mediator (HVEM). Immunity 8:21-30.[CrossRef][Medline]
/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. J. Virol. 75:4734-4743.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»